Hisamitsu Pharmaceutical Co., Inc. Provides Dividend Guidance for the Second Quarter of Fiscal 2025 and Full Year Ending February 28, 2025
July 11, 2024 at 02:00 am EDT
Share
Hisamitsu Pharmaceutical Co., Inc. provided dividend guidance for the Second Quarter of fiscal 2025 and Full Year Ending February 28, 2025. For the second quarter, the company expected dividend of JPY 43.00 against JPY 42.50 paid for the same period a year ago.
For the year, the company expected dividend of JPY 43.00 against JPY 42.50 paid for the same period a year ago.
Hisamitsu Pharmaceutical Co Inc is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the manufacture, sale and supply of pharmaceuticals and related products, and the operation of over-the-counter drug (OTC) business. It is also engaged in the manufacture and sale of drugs in the United States, Brazil, Vietnam, and Indonesia, the development work in Europe, the drug marketing and sales in China and Hong Kong. It is also engaged in the urban cable television broadcasting business, Internet connection service business, non-life insurance agency business, advertising agency business and the purchase, manufacture and sale of packing materials.
HISAMITSU PHARMACEUTICAL CO., INC. 
